# Growth Hormone Treatment in Short Children Born Small for Gestational Age

> **NCT00191529** · PHASE3 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 200 (—)

## Conditions studied

- Infant, Small for Gestational Age

## Interventions

- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00191529
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 200 (—)
- **Last updated:** 2007-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00191529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00191529, "Growth Hormone Treatment in Short Children Born Small for Gestational Age". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00191529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*